DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Art Pappas will speak on "Later Stage Venture Funding" at the University of North Carolina at Chapel Hill's Technology Commercialization Workshop in Chapel Hill.
News | 10. 21. 2010
